Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated ...
The sandbox modding community is buzzing with fresh energy in 2026, as long-awaited updates and new content releases are breathing new life into beloved titles like RLCraft, Garry's Mod, and Minecraft ...
US FDA grants accelerated approval to Gilead’s Hepcludex for the treatment of chronic hepatitis delta virus: Foster City, California Tuesday, May 26, 2026, 10:00 Hrs [IST] Gilea ...
FDA approves Gilead’s Hepcludex as the first treatment for chronic hepatitis delta virus in the U.S., marking a major ...
The agency approved an 8.5mg dose for adults with chronic HDV. Its approval was based on reductions in HDV RNA and the normalization of alanine aminotransferase based on results f ...
FDA approves 1st chronic HDV treatment Hepcludex to reduce virus levels and improve liver function in adults with hepatitis delta virus.
The FDA approved Hepcludex injection for the treatment of chronic hepatitis D infection in adults without cirrhosis or with ...
Zacks.com on MSN
GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy
Gilead Sciences, Inc. GILD announced that the FDA has granted accelerated approval to Hepcludex (bulevirtide-gmod) for adults with chronic hepatitis delta virus (HDV) infection. The approval makes ...
U.S. Food and Drug Administration (FDA) approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results